Fuge Liebo Tang Jiaonang (伏格列波糖胶囊)伏格列波糖胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 浙江震元制药有限公司Chinese legal name: 浙江震元制药有限公司
主要成分Active Ingredients
- 伏格列波糖Fuge Liebo Tang
- 环已四醇Huanyi Sichun
药物知识说明
伏格列波糖是一种在国家药监局注册认定的药品。该药品含有伏格列波糖-fb111b8b等成分。
该药品关联的活性成分包括：伏格列波糖Fuge Liebo Tang。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：浙江震元制药有限公司Chinese legal name: 浙江震元制药有限公司。
您可以探索含有相同成分的其他药品：伏格列波糖-fb111b8b成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 伏格列波糖胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 伏格列波糖Fuge Liebo Tang.
Manufacturers recorded for this product: 浙江震元制药有限公司Chinese legal name: 浙江震元制药有限公司.
Explore other medicines containing the same ingredient: 伏格列波糖 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 伏格列波糖胶囊Recorded Chinese name: 伏格列波糖胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.2mg*30粒0.2 mg × 30 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 浙江震元制药有限公司Chinese legal name: 浙江震元制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20060234
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20060234
Manufacturer
Chinese legal name: 浙江震元制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep tightly closed.
Specification
0.2 mg × 30 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字H20060234
生产企业
浙江震元制药有限公司(国产)
适应症
改善糖尿病饭后高血糖（本品只适用于患者接受饮食疗法、运动疗法没有得到明显效果时，或者患者除饮食疗法、运动疗法外还用口服降血糖药物或胰岛素制剂而没有得到明显效果时）。
用法用量
成人0.2mg/次，饭前口服。疗效不明显时，可将1次增量至0.3mg。
不良反应
有时出现低血糖。腹部胀满、排气增加。偶尔出现肠梗阻样症状。偶见伴有黄疸、GOT、GPT升高的严重肝功能障碍，腹泻、便秘、食欲不振、恶心、呕吐、过敏反应。
禁忌
严重酮症、糖尿病昏迷或昏迷前的患者，严重感染、手术前后、严重创伤的患者。
注意事项
正在服用其它糖尿病药物的患者、有腹部手术史或肠梗阻史的患者、伴有消化和吸收障碍的生肠道疾病的患者、重度疝、结肠狭窄、溃疡患者、严重肝、肾功能障碍的患者、妊娠及哺乳妇女以及老年患者慎用。
贮藏
密封保存。
规格
0.2mg*30粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.